微創醫療(00853.HK):上海微創電生理醫療科技引入新投資者
格隆匯 8 月 5日丨微創醫療(00853.HK)公告,於2020年8月5日,集團旗下聯營公司上海微創電生理醫療科技股份有限公司("微創電生理")與若干投資者訂立協議,以增加其資本。
根據與投資者訂立的協議,天津熔信企業管理合夥企業("天津熔信")作為領投方,天津遠翼元福企業管理中心("天津遠翼")、廣州粵民投雲譯股權投資合夥企業(有限合夥)("粵民投雲譯")及上海張江火炬創業投資有限公司("張江火炬創業")作為跟投方同意向微創電生理注資,總投資金額合計為人民幣3億元。
投資者注資的金額經參考多項因素(包括微創電生理的融資需要、微創電生理所開發產品及微創電生理的發展及增長潛力的整體因素)後經訂約方公平磋商釐定。於完成增資後,微創電生理的估值將達到人民幣48億元。
增資及引入新的戰略投資人能夠為微創電生理帶來產品研發、製造和市場開拓所需的營運資金,從而有助微創電生理提高其市場競爭力、拓寬市場資源及促進快速發展。
增資及引入新的戰略投資人也有利於提升集團於微創電生理的投資價值,以及進一步提升集團品牌影響力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.